3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Prostatic Neoplasms
8
Breast Neoplasms
8
Vitamin D Deficiency
7
Polycystic Ovary Syndrome
4
Leukemia, Lymphocytic, Chronic, B-Cell
3
Warts
2
Rectal Neoplasms
2
Osteoporosis
2
Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Stroke
1
Spinal Cord Injuries
1
Seizures
1
Psoriasis
1
Prostate Adenocarcinoma
1
Polyps
1
Pathologic Processes
1
Pain
1
Ovarian Neoplasms
1
Osteoarthritis
1
Obesity
1
Neoplasms by Site
1
Myelodysplastic Syndromes
1
Meningitis
1
Melanoma, Cutaneous Malignant
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Interventions
Rituximab
131
Cyclophosphamide
74
fludarabine phosphate
51
Whole-Body Irradiation
38
Peripheral Blood Stem Cell Transplantation
36
Mycophenolic Acid
36
Tacrolimus
32
Etoposide
28
Busulfan
28
Melphalan
24
Lenalidomide
23
Prednisone
22
Filgrastim
22
Cyclosporine
22
Bortezomib
22
Antilymphocyte Serum
21
Vincristine
19
Methotrexate
19
obinutuzumab
17
Bendamustine Hydrochloride
16
fludarabine
15
Doxorubicin
15
Radiotherapy
14
ibrutinib
13
Dexamethasone
13
Cytarabine
13
Cord Blood Stem Cell Transplantation
13
Carmustine
13
pembrolizumab
12
idelalisib
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, Follicular
×
Cholecalciferol
×
Clear all
NCT03078855
2024-09-04
ILyAD
University of Rochester
Phase 3
Completed
211 enrolled
13 charts